RICHMOND, Calif., Sept. 10 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO - News) announced today that Edward Lanphier, Sangamo’s president and chief executive officer, will provide an update on the progress of Sangamo’s ZFP Therapeutic development programs and an overview of the company’s business strategy at 1:30 pm (PT) on Monday, September 17, 2007 at the ThinkEquity Partners’ 5th Annual Growth Conference in San Francisco.
